Q2 2019 13F Holders as of 30 Jun 2019
-
Type / Class
-
Equity / Common Stock, no par value
-
Shares outstanding
-
109,272,143
-
Total 13F shares
-
573,234
-
Share change
-
+382,586
-
Total reported value
-
$975,780
-
Price per share
-
$1.70
-
Number of holders
-
13
-
Value change
-
+$645,305
-
Number of buys
-
5
-
Number of sells
-
7
Institutional Holders of ONCOLYTICS BIOTECH INC - Common Stock, no par value (ONCY) as of Q2 2019
As of 30 Jun 2019,
ONCOLYTICS BIOTECH INC - Common Stock, no par value (ONCY) was held by
13 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
573,234 shares.
The largest 10 holders included
Verition Fund Management LLC, MORGAN STANLEY, SCOTIA CAPITAL INC., COMERICA BANK, ROYAL BANK OF CANADA, Magnus Financial Group LLC, Federation des caisses Desjardins du Quebec, BANK OF MONTREAL /CAN/, DEUTSCHE BANK AG\, and NEXT Financial Group, Inc.
This page lists
13
institutional shareholders reporting positions in this security
for the Q2 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.